COVID-19 – Page 3 – HealthQuill

Lysolipid, a byproduct of the human immune response to viruses and bacteria, may be behind lung instability caused due a life-threatening illness— acute respiratory distress syndrome, researchers said.

Excess lysolipids may be main reason for acute respiratory distress syndrome

HQ Team March 13, 2024: Lysolipid, a byproduct of the human immune response to viruses and bacteria, may be behind lung instability caused.

by HealthQuill
March 13, 2024
0 Comments

An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but rather strengthened, researchers said.

Drugs Health Pharma

German male injects Covid-19 vaccines 217 times, immunity didn’t weaken

HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.

by HealthQuill
March 7, 2024
0 Comments

The US Centers for Disease Control and Prevention Control has revised its Covid-19 isolation recommendations by suggesting patients return to normal activities if they are free of fever for at least 24 hours.

Drugs Health Pharma

CDC revises isolation guidance for Covid-19 patients in the US

HQ Team March 2, 2024: The US Centers for Disease Control and Prevention Control has revised its Covid-19 isolation recommendations by suggesting patients.

by HealthQuill
March 2, 2024
0 Comments

About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave of the Covid-19 pandemic, according to a study.

Drugs Health Pharma

Antimalarial drug may have killed 17,000 people in first Covid-19 wave

HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave.

by HealthQuill
January 8, 2024
0 Comments

The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.

Drugs Health Pharma

JN.1 sub-variant Covid-19 cases rise to 62% in the US, says CDC

HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared.

by HealthQuill
January 8, 2024
0 Comments

Moderna Inc., expects to break even in 2026 as it aims to drive profits by “disciplined investment” and organic sales growth.

Drugs Health Pharma

Moderna expects to break even in 2026, says CEO Stéphane Bancel

HQ Team January 5, 2023: Moderna Inc., expects to break even in 2026 as it aims to drive profits by “disciplined investment” and.

by HealthQuill
January 5, 2024
0 Comments

Remember that Covid-19 is still with us, continuously evolving and forming new lineages and we still need to stay ahead of it. Maintaining a cautious vigilance rather than undue panic is the need of the day.

Drugs Health Pharma

Opinion: Covid-19 variant needs cautious vigilance, not undue panic

By K. Leelamoni The coronavirus variant JN. 1 has been causing concern among health experts and the public alike. JN.1 is surging in.

by HealthQuill
December 26, 2023
0 Comments

Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of the Covid-19 virus to contribute to their persistence and recurrence of the infection, a study finds.

Drugs Health Pharma

Human lipid particles may be hidden reservoirs of Covid-19 virus

HQ Team December 13, 2023: Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of.

by HealthQuill
December 14, 2023
0 Comments

Mosquitoes by the evening. Image Credit: Wolfgang Hasselmann on Unsplash

Climate Drugs Pharma

WHO global malaria strategy ‘off track by a wide margin’

HQ Team November 30, 2023: The Covid-19 pandemic significantly disrupted malaria services, leading to a surge in both incidence and mortality rates, exacerbating.